ReviewChemical & biomedical imaging2026
Electrochemiluminescence Imaging for In Situ Electrocatalysis Characterization: Recent Progress and Mechanistic Insights.
Review in Chemical & biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanistic insights into electrochemiluminescence: fueling advances in bioanalysis and imaging.Chemical science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrochemiluminescence (ECL) imaging has emerged as a powerful optical microscopy technique due to its high sensitivity and exceptional spatiotemporal resolution. When integrated with electrocatalysis, ECL imaging serves as a promising in situ tool for characterizing catalytic processes. In this Perspective, we first introduce the signal transduction principles of ECL imaging tailored for electrocatalysis. Subsequently, we systematically summarize its diverse applications, ranging from the real-time monitoring of catalytic interfaces and high-throughput screening of single catalysts to the evaluation of subparticle heterogeneity. Notably, we also discuss how ECL imaging provides refined mechanistic insights into catalytic activity, surpassing the capabilities of traditional methods. Finally, current challenges and future perspectives are discussed, aiming to provide a roadmap for the further development of ECL imaging in uncovering complex catalytic mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.